| Type : |
Journal |
| Internett-koblingen : |
https://doi.org/10.1007/s40268-019-0264-1 |
|
| Forskerteamet : |
Menges - Novartis, Menges, Slovenia |
| Forfattere : |
Vimpolsek M, Gottar-Guillier M, Rossy E. |
| Tittel : |
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. |
| Nummer : |
Drugs R D 19: 127–140. 2019 |
|
| Nivå of Evidence : |
|
| Fysisk stabilitet : |
|
| Kjemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
| Proteiner: biologisk aktivitet i cellekultur |
|
Lister
 Infliximab
|
 |
 |
 |
 |
10 mg/ml |
2-8°C |
 |
| 30 |
 |
|
 |
|
|
|
10 mg/ml |
23-27°C |
|
| 14 |
|
|
|
|
 |
 |
0,4 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
0,4 mg/ml |
23-27°C |
|
| 30 |
|
|
|
|
|
|
4 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
4 mg/ml |
23-27°C |
|
| 30 |
|
|
|
|
|
